New 2021 Forecasts Released

New Data

Global Hernia Repair Mesh Market

10 Pages | 14 Exhibits | Forecasts Through 2024
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now
Talk to Sales

Overview

This report from Life Science Intelligence provides the latest market data for the Global Hernia Repair Mesh Market. Information covered by this report includes:

·        unit volumes & pricing forecast from 2019-2024

·        analyses of the leading companies, and

·        global market share analysis.

The global market for hernia repair mesh was valued at an estimated $3.5 billion in 2020 and is projected to increase at a CAGR (2020-2024) of 9.1%. Products covered by this report include implantable hernia meshes for hernia repair and reconstruction procedures.

This report covers the impact of COVID-19 on the hernia repair mesh market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as BD, Johnson & Johnson subsidiary Ethicon, Medtronic, W.L. Gore, and others. The report provides insights into trends, drivers, and limiters of the hernia repair mesh market, as well as highlights potential opportunities.

The hernia repair mesh market was negatively impacted by the COVID-19 pandemic. The pandemic has affected elective surgical procedures markedly, as many non-critical procedures have been cancelled or postponed so that healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients. The market and procedures utilizing these products are projected to slowly recover in 2021.

The leading competitors in the hernia repair mesh market are BD, Ethicon (J&J) & LifeCell. These companies accounted for more than 80% of the global market share. Major competitors in the market, including BD (Bard), Ethicon, and Atrium Medical have recalled more than 211,000 units of meshes since 2005 as post-surgery complication rates are as high as 20%. However recently FDA approved devices offer better positioning systems and articulation during implantation that may potentially mitigate some of the safety and efficacy concerns with these types of products. 

Companies Covered

  • Atrium Medical/Maquet
  • Bard/BD
  • Cook
  • Ethicon J&J
  • Exogenesis
  • Gore
  • LifeCell
  • Medtronic
  • Novus Scientific
  • RTI Surgical

Our Clients